Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation.

Emil KostovskiElena FrigatoMladen SavikjAnders DahmPer Morten SandsetMarie-Christine MowinckelGrethe SkrettingBjarne ØsterudCristiano BertolucciPer Ole Iversen

Published in: Spinal cord (2018)

Financial support was provided from the Throne Holst Foundation, Sunnaas Rehabilitation hospital and the University of Ferrara (FAR2016).

Keyphrases

double blind
gene expression
placebo controlled
clinical trial
phase iii
dna methylation
open label
phase ii
healthcare
study protocol
acute care
resting state
adverse drug
randomized controlled trial
functional connectivity
emergency department
affordable care act
young adults